Ryan Erdman is an IPilogue Writer and a 2L JD Candidate at Osgoode Hall Law School. In a truly monumental achievement in scientific innovation, there are now over a dozen authorized COVID-19…
Category: Development
in Access to Medicines, Blogs, Commercialization, Development, Innovation, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
887
Broken Promises: Utility Standards and Patent Applications in Canada
The last day of June 2017 saw the Supreme Court of Canada (SCC) quash the controversial Promise Doctrine. The issue at hand in AstraZeneca Canada Inc v Apotex Inc was…
in Access to Medicines, Commercialization, Design, Development, IP, Patentability, Patents, Pharmaceutical Drugs, Uncategorized0by Editor
1336
What Makes It My Molecule: A Look at Professor Ronald Pearlman’s Genome Editing Work
This past November, Professor Ronald E. Pearlman from York University’s Department of Biology gave a talk [1] at Osgoode Hall Law School to discuss the potential of the innovative CRISPR…
in Blogs, Cybersecurity, Development, Electronic Databases, events, Innovation, Technology, US0by Editor
1006
The Partnership on AI: A Modern Manhattan Project?
On June 29, Sam Harris delivered a TED Talk in which he posed the question: “can we build artificial intelligence without losing control of it?” He proposed the founding of “something like…
Pole Vault in Rio 2016: A Contest of Skill or a Contest of Patents?
With the Rio 2016 Summer Olympics getting started on August 5th, there is no time like the present to explore the evolution of patents relating to the vaulting pole. Originally, pole…
The Future of Copyright in a Global Context
This past March, Toronto hosted the 55th Annual Convention of the International Studies Association (ISA). This year’s ISA Annual Convention brought together over 5300 scholars, practitioners, and students to discuss…